Albuterol Sulfate Inhalation Solution, 0.083 percent (Nephron Pharmaceuticals): Recall - Aseptic Processing Simulation Results
Finding of bacterial growth.
Finding of bacterial growth.
Tissue surrounding the Amplatzer ASO can break down (erode) and result in life-threatening emergencies that require immediate surgery.
May result in the inability to access certain menu functions which could possibly lead to delay in treatment.
A unique sequence of inputs and a collapsed bellow could result in delivery of higher-than-expected tidal volume.
L’Agenzia Italiana del Farmaco rende disponibile nuove e importanti informazioni su agomelatina (Valdoxan/Thymanax).
Health care professionals should consider for each patient, whether the benefits of Iclusig treatment are likely to exceed the risks of treatment.
May increase blood pressure and/or pulse rate and can present a significant risk for patients with a history certain cardiovascular conditions or stroke.
May increase blood pressure and/or pulse rate and can present a significant risk for patients with a history certain cardiovascular conditions or stroke.
May increase blood pressure and/or pulse rate and can present a significant risk for patients with a history certain cardiovascular conditions or stroke.
L’Agenzia Italiana del Farmaco rende disponibile importanti informazioni sull'utilizzo del lotto D01U27121R di KEYVENB e speciali avvertenze e istruzioni per l’uso.
80.211.154.110